BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 662170)

  • 1. [Results of a clinical study of a group of hospitalized diabetics under treatment with depot buformin].
    Durante F; Scaffidi A; Rotolo G; Rini GB
    Minerva Med; 1978 May; 69(24):1665-72. PubMed ID: 662170
    [No Abstract]   [Full Text] [Related]  

  • 2. [The biguanides in the treatment of late florid diabetes of recent diagnosis: controlled trial of delayed-action buformin and placebo].
    Angeli G; Baraldi B; Ciaramelli F
    Clin Ter; 1977 Jun; 81(5):453-62. PubMed ID: 328220
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics].
    Bruneder H; Klein HJ
    Acta Med Austriaca; 1978; 5(3):88-90. PubMed ID: 752220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavior of IRI and some blood lipid indices after buformin administration].
    Quartarone M; Saitta A; Caruso G; Monacciani U; Perdichizzi G; Squadrito G
    Minerva Med; 1979 May; 70(22):1623-8. PubMed ID: 450301
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical use of a new hypoglycemic agent: buformin].
    Leone S; Modicano V; Scapellato L
    Clin Ter; 1976 Sep; 78(6):527-35. PubMed ID: 1017159
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vitamin B12-level in serum of diabetics receiving long-term buformin therapy].
    Müller P; Fischer H; Sorger D
    Z Gesamte Inn Med; 1981 Mar; 36(6):226-8. PubMed ID: 7257460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral antidiabetic monotherapy and combination treatment with glybenclamide (HB 419) and biguanides of insulin receiving diabetics of the adult type].
    Knick B; Wendt O; Konder ML; Netter P
    Med Klin; 1970 Jan; 65(3):109-12. PubMed ID: 5519048
    [No Abstract]   [Full Text] [Related]  

  • 8. [A contribution to the study of the effect of bigvanides in the skeletal muscle of diabetics (author's transl)].
    Vondra K; Bass A; Brunová E; Slabochová Z; Teisinger J; Vítek V
    Cas Lek Cesk; 1978 Jul; 117(29-30):892-4. PubMed ID: 688313
    [No Abstract]   [Full Text] [Related]  

  • 9. [The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)].
    Irsigler K; Kritz H; Regal H; Foltin E
    Wien Klin Wochenschr; 1978 May; 90(10):332-7. PubMed ID: 654296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vitamin B 12 absorption disorders in diabetic patients treated with adebit].
    Keszthelyi B; Tóth A; Novotny S; Fónay K; Jávor T; Past T; Bero T
    Orv Hetil; 1976 Apr; 117(16):963-4. PubMed ID: 1272562
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum concentration of lactate in diabetic patients treated with biguanides in relationship to renal function (author's transl)].
    Sailer D; Ganawal S; Berg G
    Med Klin; 1979 Mar; 74(9):318-24. PubMed ID: 423858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effect of buformin, a biguanide, on insulin sensitivity, soluble fraction of tumor necrosis factor receptor and serum lipids in overweight patients with type 2 diabetes mellitus.
    Ohara S; Komatsu R; Matsuyama T
    Diabetes Res Clin Pract; 2004 Nov; 66(2):133-8. PubMed ID: 15533580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative studies of the effect of N1-n-butylbiguanide hydrochloride (Buformin) and N1-n-butylbiguanide tosylate (Buformin retard)].
    Singer P; Thoelke H
    Z Gesamte Inn Med; 1973 Aug; 28(16):504-6. PubMed ID: 4767598
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
    Vogel G; Krummel E
    Arzneimittelforschung; 1969 Jul; 19(7):1128-30. PubMed ID: 5394514
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indications and contraindications to the diabetes mellitus therapy by biguanide derivatives in the light of the metabolic and epidemiologic studies (author's transl)].
    Tatoń J; Kowalik-Borówka E
    Przegl Lek; 1979; 36(7):553-7. PubMed ID: 504704
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative evaluation of the effect of diet, pharmaco- and balneotherapy on a number of metabolic indices in obesity].
    Lukasheva MV; Mokina MN
    Vopr Kurortol Fizioter Lech Fiz Kult; 1982; (3):46-50. PubMed ID: 7113038
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of diabetes mellitus with combination of sulfonyl urea and biguanide].
    Aoki H; Kawanishi M; Nagano M
    Saishin Igaku; 1969 Mar; 24(3):610-4. PubMed ID: 5772840
    [No Abstract]   [Full Text] [Related]  

  • 18. [Follow-up study on the effects of buformin on the serum vitamin B-12 level and on the motility of the stomach and small intestine in diabetics].
    Brunová E; Slabochová Z; Hrubá F; Nováková V; Bejblová O; Vondra K
    Vnitr Lek; 1978 Mar; 24(3):277-81. PubMed ID: 644896
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of biguanids on the lactate metabolism. Studies in diabetics under submaximal ergometric exercise (author's transl)].
    Pilger E; Schmid P; Goebel R
    Med Klin; 1979 Jun; 74(22):859-65. PubMed ID: 470783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of buformin on the metabolism of skeletal muscles in diabetic rats].
    Strohfeldt P; Strubel-Obermaier U; Kettl H
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():771-4. PubMed ID: 142394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.